Advertisement

5 Responses

  1. Bernard Farrell
    Bernard Farrell April 26, 2013 at 5:51 am | | Reply

    I’d like to know whether Lilly is working on faster insulins, quicker onset and shorter duration time. They probably can’t go into too many details about that.

    I’d also like to know why the cost of Humalog is still so high and why (I believe) they’re blocking a generic form of that. According to CVS Caremark, my current mail order pharmacy, 12 vials of Humalog costs $1647.19, most of this paid for by my employer. That seems a lot for a drug that was first sold in 1996.

  2. Andrea
    Andrea April 26, 2013 at 6:57 am | | Reply

    This may seem petty, but I’d love an update on when they think the books might be available online. I know we can ask our CDE but I wouldn’t feel right. I think it’s more important for a family facing a new dx to have the hard copy in hand. I don’t want to take from that supply.

  3. Lisa
    Lisa April 26, 2013 at 7:03 am | | Reply

    Ask Lilly when are they going to develop a pen like the Pendiq here in the US? I’m not ready for a pump yet and need a pen that has both a memory feature and can bolus smaller than 0.5U of insulin at a time.

  4. Andrea
    Andrea April 26, 2013 at 7:08 am | | Reply

    Oh I thought of one. Are they in the process of changing the design of the glucagon to more like the GlucaPen? I really think that there is so much resistance in schools/states because of it’s current design. I think if it resembled more like an EpiPen, like the GlucaPen does, then it would be easier in the school battle.

  5. kathy
    kathy April 27, 2013 at 5:06 am | | Reply

    I would like to hear an update on the Diabetes Alert Dog program that Lilly is involved with at ICAN under Dr. Dana Hardin. They are studying what the dogs actually detect in the high or low glucose scents. Its the only scientific study that I am aware of for diabetes alert dogs and their training, which truly is a science.

Leave a Reply